A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis

BACKGROUND: Juvenile idiopathic arthritis (JIA) is an inflammatory arthritis of unknown etiology, which lasts for greater than 6 weeks with onset before 16 years of age. JIA is the most common chronic rheumatic disease in children. NSAIDs have been the mainstay of initial management with naproxen (N...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Pediatr Rheumatol Online J
Главные авторы: Lovell, Daniel J., Dare, Jason A., Francis-Sedlak, Megan, Ball, Julie, LaMoreaux, Brian D., Von Scheven, Emily, Reinhardt, Adam, Jerath, Rita, Alpan, Oral, Gupta, Ramesh, Goldsmith, Donald, Zeft, Andrew, Naddaf, Henry, Gottlieb, Beth, Jung, Lawrence, Holt, Robert J.
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2018
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6019234/
https://ncbi.nlm.nih.gov/pubmed/29941047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12969-018-0260-y
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы